The gain of function of p53 mutant p53S in promoting tumorigenesis by cross-talking with H-RasV12.

International Journal of Biological Sciences
Shuting JiaYing Luo

Abstract

The loss of wild type p53 tumor suppressive function and oncogenic gain-of-function of p53 mutants have been showing important implications in tumorigenesis. The p53(N236S) (p53(N239S) in human, p53S) mutation has been shown to lose wild type p53 function by yeast assay. However, its gain of function is still not clear. By gel shift assay, we showed that mutant p53S had lost its DNA binding ability to its target promoters. Further real-time PCR data confirmed that p53S had lost the function of regulating the transcription of p21( Cip1/Waf1), cyclin G, PUMA, and Bax in response to 10Gy irradiation. These data confirmed the loss of function of p53S in mammalian cells. By xenograft assay, we showed that the p53S per se was not oncogenic enough to form tumor, however, cooperating with H-RasV12, p53S could dramatically promote tumorigenesis in p53 null MEFs. Further study showed that co-expression of p53S and H-RasV12 could increase the expression level of H-RasV12 and partially eliminate the elevation of stress response proteins such as Chk2, γ-H2AX, Hsp70, Rb, p16(Ink4a) caused by either p53S or H-RasV12. These data suggested that p53S cross-talked with H-RasV12 and reduced the cellular stress response to oncogenic signals, which ...Continue Reading

References

Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J TrentB Vogelstein
Jan 1, 1994·Current Biology : CB·T JacksR A Weinberg
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·G S FiresteinD R Green
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·P V NikolovaA R Fersht
Jun 12, 1999·Arthritis and Rheumatism·Z HanG S Firestein
Oct 29, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K L MurphyJ M Rosen
Jan 17, 2002·Human Mutation·Andrew C R MartinJanet M Thornton
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shunsuke KatoChikashi Ishioka
Oct 1, 2004·Molecular and Cellular Biology·Wendy BruinsAnnemieke de Vries
Oct 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·Andreas C JoergerAlan R Fersht
Dec 1, 2006·Nature·Raffaella Di MiccoFabrizio d'Adda di Fagagna
Sep 20, 2008·Cancer Gene Therapy·M OlivierP Hainaut
Dec 9, 2008·Cancer Cell·Ignacio Dolado, Angel R Nebreda
Aug 21, 2009·Nature Reviews. Cancer·Ran Brosh, Varda Rotter
Aug 25, 2009·The Journal of Biological Chemistry·Kian Hoe KhooAlan R Fersht

❮ Previous
Next ❯

Citations

Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Jan 21, 2017·Journal of Cellular Biochemistry·Jing LiuYing Luo
Dec 25, 2012·Yi chuan = Hereditas·Yong-Yong WeiYing Luo
Aug 9, 2020·Frontiers in Oncology·Ulyana A BoyarskikhMaxim Leonidovich Filipenko
Dec 3, 2014·Cold Spring Harbor Protocols·Chu-Xia Deng

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
fluorescence microscopy

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.